In many studies comparing a new "target treatment" with a control target treatment, the received treatment does not always agree with assigned treatment -that is, the compliance is imperfect. An obvious example arises when ethical or practical constraints prevent even the randomized assignment of receipt of the new target treatment but allow the randomized assignment of the encouragement to receive this treatment. In fact, many randomized experiments where compliance is not enforced by the experimenter (e.g., with non-blinded assignment) may be more accurately thought of as randomized encouragement designs. Moreover, often the assignment of encouragement is at the level of clusters (e.g., doctors) where the compliance with the assignment varies across the units (e.g., patients) within clusters. We refer to such studies as "clustered encouragement designs" (CED) and they arise relatively frequently (e.g., Sommer and Zeger, 1991; McDonald, Hiu, and Tierney, 1992; Dexter et al., 1998) . Here, we propose Bayesian methodology for causal inference for the effect of the new target treatment vs. the control target treatment in the randomized CED with all-or-none compliance at the unit level, which generalizes the approach of Hirano, Imbens, Rubin, and Zhou (2000) in important and surprisingly subtle ways, to account for the clustering, which is necessary for statistical validity. We illustrate our methods using data from a recent study exploring the role of physician consulting in increasing patients' completion of Advance Directive forms.
INTRODUCTION AND PURPOSE. 1¡ Motivating studies and data features.
When evaluating treatment options, direct assignment and enforcement of treatment receipt may not be ethical or feasible. In such cases, it is more realistic to view the design as involving the randomization of encouragement, as opposed to receipt, of the two target treatments, new and standard, where in some designs the encouragement is explicit and no enforcement is even attempted. Commonly, moreover, this encouragement is applied to clusters (e.g., physicians or villages) of subjects (e.g., patients). An example of such a "clustered-encouragement-design" (CED) was reported by Sommer and Zeger (1991) where investigators randomized villages in Indonesia to offer or not vitamin A supplements to all their infants, but not all infants in the villages assigned to get vitamin A actually received it. Another example of the CED was a study to evaluate a vaccine for influenza, where any randomized withholding of the vaccine was considered unethical (McDonald, Hiu, and Tierney, 1992; Hirano, Imbens, Rubin, and Zhou, 2000) ; for this reason, investigators randomized physicians to receive or not receive encouragement to vaccinate their patients, but many patients of the encouraged doctors did not receive a flu shot, and some patients of the not-encouraged doctors did receive the shot.
A more recent example of a CED was conducted on Advance Directive (AD) forms (Dexter et al., 1998) , which are intended to be completed by patients to allow them to make early decisions about medical treatments at the late stages of life (instructional directives), and designate a representative decision maker (proxy directives) (Wenger et al., 1993) . Dexter et al. (1998) randomized physicians to receive or not receive encouragement to discuss AD with patients; the outcome was patient completion of AD, and the original study addressed the effect of encouragement on AD completion (Dexter et al., 1998) . For our purpose, however, an equally important substantive research goal is to assess the effect of physicians' discussion of AD as the new target treatment for potentially increasing patients' completion rates of the forms relative to the control target treatment of no such discussion (e.g., Miles et al., 1996) .
Generally, CED studies share two specific data-structure aspects. First, there is frequent noncompliance of individual subjects -not clusters -for the new target treatments within randomized encouragement arms. Second, the distribution of noncompliance and outcomes frequently varies within and between clusters, which are the units of randomization, rather than the individual subjects. We consider CED studies where the compliance for target treatments is by definition (or for practical purposes) all or none (for extensions, see Sec. 5). This type of noncompliance means that there exist, essentially, two subgroups of patients who are not fully identifiable from the data: those who would not change their actual behavior concerning the target treatment no matter what their physician's assignment -the noncompliers, and those who would comply under both assignment -the compliers (e.g., Imbens and Rubin, 1994; Baker and Lindeman, 1994; Angrist, Imbens, and Rubin, 1996; Baker, 1998; Frangakis and Rubin, 1999) .
These definitions are local to this particular study and do not suggest compliance or not in other studies.
An intention-to-treat (ITT) analysis is especially appropriate when the randomized intervention is the scientific intervention -the target treatment -of interest. However, the CED uses randomized encouragement only as a surrogate to induce the new target treatment, and ITT analysis is not as appropriate for two reasons. First, the noncompliers arguably do not carry information about the comparison between the target treatments (e.g., biological efficacy or side effects) because, by definition of this group, the randomization cannot change receipt of target treatment; for relevant discussion between explanatory and pragmatic comparisons, see Sheiner and Rubin (1996) and Armitage (1998) . Second, the noncompliers may experience effects of encouragement. For example, in the study on flu shots (McDonald, Hiu, and Tierney, 1992) , it is possible that, for noncomplying physician-patient pairs, the encouragement has triggered physicians to suggest to their patients a number of other precautions against flu in addition to vaccination, and which might not have been taken in the absence of the encouragement; These are pure "encouragement" effects that confound the effect of vaccination if the noncompliers are included in the ITT analysis.
The second aspect common in CED studies, the clustered structure of units, also has methodological implications. Because the assigned encouragement is at the cluster level, assignment is ignorable (Rubin, 1978) only conditionally on the clusters. And, because noncompliance and outcomes can vary both within and between clusters, the interactions between clustering, noncompliance and outcomes need to be addressed.
1¡ 2. Addressing clustering with noncompliance at the individual level.
The problem of noncompliance has received increasing attention recently. In particular, it is now generally recognized that the approach of focusing on the compliers, who are not generally fully identifiable from observed data (e.g., Sommer and Zeger, 1991; Baker and Lindeman, 1994; Angrist et al., 1996) , is critically different from approaches that use the treatment actually received as if it were randomized, such as "as-treated" or "per-protocol" approaches, whose bias has been well documented (e.g., Rubin, 1991; Mark and Robins, 1993; Robins and Greenland, 1994; Sheiner and Rubin, 1996) . Moreover, implicit assumptions in the standard "instrumental variables" analyses, such as the a priori exclusion of effects of assignment, have now formal expressions , thereby allowing researchers to avoid such exclusion assumptions when they are not plausible. In related work without the exclusion restriction, Robins (1989) derived estimated bounds for treatment effects, Imbens and Rubin (1997a) developed an appropriate Bayesian approach for distinct patient-physician pairs, and, for the latter case, recently, Hirano et al. (2000) have modeled covariate information.
Research on clustered data, on the other hand, has a long history in interconnected literatures including: survey methodology, dating back at least to Neyman (1934) , and Hansen and Hurwitz (1943) ; random effects, dating to Hartley and Rao (1967) , Harville (1976) and Laird and Ware (1982) ; estimating equations methods (e.g., Liang and Zeger, 1986) ; hierarchical Bayesian and Empirical Bayesian methods dating to James and Stein (1961) , Efron and Morris (1973) , Rubin (1981) , and others. In more recent work on clustered randomization with noncompliance, Frangakis, Rubin, and Zhou (1998) relaxed the exclusion restrictions but offered limited information on the role of covariates and on the influence of prior distributions, whereas Korhonen et al. (2000) focused on analyses under the exclusion restrictions.
Here, we investigate the broader combined problem of clustered encouragement followed by individual noncompliance, and thereby propose general methodology for causal inference in studies where these two data structures are present together, and where structural exclusion restrictions are relaxed. In the next section we introduce notation and formalize our goal. In Sec.
3 we discuss models and methodology: within an abstract phenomenological Bayesian model (Rubin, 1978) , we introduce an appropriate framework for causal inference with clustered data suffering from noncompliance. We discuss the critical role of clustering and covariates, and propose a flexible submodel. In Sec. 4 we illustrate our methods by analyzing data from the study on AD forms. The final section offers concluding remarks. The appendix gives details on our models.
CLUSTERED ENCOURAGEMENT DESIGN 2¡ 1. Setting.
Consider a hospital serving a group of patients, , so that each physician may serve more than one patient.
In order to compare two target treatments, a new one versus a control one, assume that the hospital considers two possible actions for each physician: (i) encouraging the physician to administer the new target treatment, and (ii) no encouragement. In either case, however, patients within a physician may not comply with their physician's assignment. To allow for this, we adopt the formulation of Angrist et al. (1996) 
(e.g., Imbens and Rubin, 1994; Pearl, 1994; Baker and Lindeman, 1994; Angrist et al., 1996; Baker, 1998; Barnard et al., 2001 ).
Because membership to those four strata, unlike membership to observed compliance strata, is unaffected by encouragement, we call them "compliance principal strata" (for manifestations of principal strata in more general settings, see Frangakis and Rubin, 2000) .
Although the encouragement to use the new target treatment may or may not induce its actual receipt for some patients, we assume that, in this context, the encouragement would not reverse a decision to take the new target treatment. This assumption was termed monotonicity by Imbens and Angrist (1994) , and allows only for the first three principal strata, that is, defiers are not allowed.
By definition, the principal strata of noncompliers -the never-takers and always-takers, are those for whom different assignment in this experiment would not change their behavior with respect to the target treatments, and therefore those groups are not relevant for comparing the target treatments (e.g., Sommer and Zeger, 1991; Sheiner and Rubin, 1996) . Moreover, if the randomized treatment is encouragement for vaccination, then other effects may be present if the encouraged physicians suggest to patients alternative preventive measures, such as recommendations to reduce the patients' exposure, prescriptions of other medicines, or earlier taking of the vaccine. Such "pure encouragement" effects are arguably more dominant for noncompliers than for compliers, because compliers experience both the effect of encouragement and the effect of the target treatment. Also, discerning "pure encouragement" effects among compliers requires assumptions not verifiable even with knowledge of all memberships to the compliance principal strata in the study. Nevertheless, because any effects of assignment @ G on outcome
4
for noncompliers must be due to sources other than the target treatment # , such effects for these patients can be removed simply by focusing analyses on the principal stratum of compliers.
For these reasons, we distinguish between the effect of encouragement on outcomes among noncompliers and among compliers. Using notation consistent with Imbens and Rubin (1997a) ,
, the subset of subjects with compliance status
, and let be the number of patients in that group. The standard ITT estimand
, where
are the average effects of assignment within compliance principal strata. In the remainder of our discussion, we focus on estimating the principal strata-specific ITT effects (2¡ 1), and, in particular, the ITT effect among the compliers, ITT j d
, the complier average causal effect (CACE).
MODELING IN THE CED 3¡ 1. Role of clustering in the phenomenological Bayesian approach.
All potentially observable data can be expressed by the matrix
. Here, # denotes the pair of potential receipts
4 is the pair of potential outcomes
may be assumed fixed over hypothetical replications of the experiment (as in a permutation-based analysis, ), we will more generally allow them to be considered random, with a distribution pr
. The joint probability distribution of k that is induced by the distribution pr
and the clustered randomiza-
, will still be denoted by pr. We assume that the matrix
contains all the information on observable data and on the design, so that the rows of k are exchangeable (Rubin, 1978) . Following results on exchangeability (de Finetti, 1974) , we may write essentially without loss of generality, write
for some distributions pr$ w (
, where w can be thought of as representing the characteristics of a larger reference population from which the study units, physicians and patients, are drawn.
We stress that, although the clustered randomization on o is likely to give less precise estimates of effects than a complete randomization at the patient level, the clustered randomization does not affect the joint exchangeability in (3¡ 1). Rather, the clustered randomization is related to the assignment mechanism: because the assignment is at the level of physicians, o , we have that pr
, so that assignment is ignorable (Rubin, 1976 (Rubin, , 1978 
, the observed data. Then, Bayesian inference on the estimands ITT e d
follows from their posterior predictive distributions induced by (3¡ 2).
3¡ 2. Role of covariates for relaxing exclusion restrictions.
Because membership to the compliance principal strata is not fully identifiable from observed data, it is important to understand how information on the principal strata-specific causal effects is recoverable.
For simplicity, assume
is binary, e.g., 1 for occurrence of disease, 0 otherwise, and
, the average causal effect within compliance principal stratum under the so-called "exclusion restrictions" (e.g., Bloom, 1984; Sommer and Zeger, 1991; Angrist et al. 1996) . However, for the reasons in Sec. 1.1, we do not wish to impose a priori these assumptions for the CED. In the absence of exclusion restrictions and of covariates, the ef-
are not consistently estimable, but bounds are (e.g., Robins, 1989; Manski, 1990; Balke and Pearl, 1997) In practice, the above discussion does not change the way Bayesian inference is drawn, but helps critically in understanding the role of covariates in recovering information. Under (3¡ 1),
Bayesian inference is based directly on the posterior predictive distribution of the target esti-
induced by (3¡ 2), where (i) in the absence of covariates, the spread of the posterior distribution will reflect the relatively large uncertainty in predicting compliance principal strata, whereas (ii) when a covariate that predicts compliance principal strata is modeled, the spread of the posterior distribution of the estimands will be narrower.
In the remaining part of this paper, we describe a specific Bayesian model and apply it to the study of AD introduced in Sec. 1.1. Asymptotic inference using estimated covariate-adjusted bounds and comparisons with small sample Bayesian inference will be discussed in detail in a subsequent article.
3¡ 3. Specific model.
We model the joint distribution pr 
. In these expres- Potential Outcomes. For our application in Sec. 4 we have binary potential outcomes so we posit the probit model, As with the model for compliance, to facilitate computations, we augment the outcome model as follows:
where, for each ; see appendix, item 4). We emphasize that this independence is not related to independence (or dependence) between outcome and compliance principal strata.
Parameters.
The parameter
is a variance-covariance matrix parameter defined below. We choose the prior distributions for w to be proper but diffuse, in order to ensure proper posterior distributions and relatively fast convergence of the fitting algorithms, but, at the same time, to be relatively noninformative for our application (Sec. 4). Given the physician-specific parameters, we posit prior distributions
independently. Here, I is the identity matrix, and º is an inflating factor, which is set by the analyst. The component of (C,1) ¹ that corresponds to the intercept is set to
and the remaining components are set to 0 to represent a prior proportion of approximately 33% for each of the three compliance principal strata.
The physician-specific parameters are assumed random with
independently across physicians would also be interesting to study more informative priors distributions. Informative priors distributions can be fitted, for example, using the same model but after introducing pseudo-subjects in the dataset (e.g., Hirano, et al., 2000) , where we can express the prior information by attaching weights to the pseudo-subjects' contribution in the likelihood based on the configuration in their covariates, cluster indicators, compliance principal strata, assignment, and outcomes.
Using model (3¡ 3)-(3¡ 7), inference for the estimands of interest,
, in the finite study population is based on (3¡ 2). The appendix outlines an algorithm for simulating these distributions for our models.
APPLICATION TO ADVANCE DIRECTIVES 4¡ 1. Procedures.
We now return to the study of AD forms introduced in Sec. 1.1. AD forms are designed to increase patient's autonomy, and although they enjoy some support by ethicists and physicians (Hughes and Singer, 1992) , few patients complete them in practice, and few physicians discuss the role of these forms with their patients. It has been hypothesized that if physicians briefly discussed the role of AD forms with their patients, this would cause completion rates to substantially increase (Miles et al. 1996) . The discussion effect is very important because, if shown large, could help convince physicians to spend the brief time needed to discuss AD forms with even more of their eligible patients. So, our goal is to address this hypothesis with a valid analysis of a CED. The problem of more flexible alternative designs in this application is studied by Frangakis and Baker (2001) .
The data we use are a subset from the study on AD forms by Dexter et al. (1998) , who analyzed the data by ITT analyses. In that study the researchers randomly divided eligible physicians of an urban hospital into four groups: one group routinely received computer reminders to discuss instructional directives with their patients; another group received reminders on proxy directives; a third group received both reminders, and a fourth group received no reminders. Here, the subset of data is from the extreme arms: the control group, denoted by $@ £ 0 2 ( , and the group receiving reminders for both AD forms, denoted by age has been previously shown to be associated with discussions of AD forms (Duffield and Podzamsky, 1996; Boyd et al., 1996; Hakim et al., 1996) . Moreover, because in a preliminary analysis, we found none of the available covariates other than age to be as useful in predicting compliance status, here we use age as the only covariate. Table 1 gives some basic characteristics of our data that can be summarized easily using theory for finite population cluster sampling (Cochran, 1963) . three quarters of the physician-patient pairs did not discuss the forms when encouraged, and so, following Sec. 2.2, they must be never-discussants in the sense that they would not discuss the forms whether encouraged or not in this study. Analogously, approximately 5% of the pairs are always-discussants. The estimated remaining approximately one fifth of physician-patient who are neither always-discussants nor never-discussants are discussion-compliers, in the sense that they would discuss AD if and only if encouraged. Therefore, although the modest 11 % ITT effect of encouragement on completion rates may suggest to physicians that discussing AD forms with their patients has no practical effect, the majority of physician-patient counted in that estimate are not relevant to the effect of AD discussion on AD completion. That is, evidence for the effect of AD discussion on AD completion needs to be sought among discussion compliers.
Generally, it is not known whether physicians or patients initiated the discussions. Nevertheless, focusing on the discussion-complier pairs almost ensures that the discussions under encouragement are initiated by physicians, because we know they would not have occurred without encouraging the physicians. Therefore, we focus on estimating the effect of encouragement on completion among the subset of discussion-compliers, ITT j d
, which, here, we call the effect of discussion on form completion. To estimate ITT U d 
We take the vector
is set here to 5, although other values were also tried (see also Sec. 4.3).
The second procedure uses patients' age in the model components ( 3¡ 3 In Table 2 , we report estimates of the estimands: compliance principal strata-specific percentages of AD completion under control, under encouragement, and the between-arm (encourage- The model that accounts for clustering but does not model age gives, mostly, unhelpfully broad answers, consistent with the role of clustering and covariates discussed, respectively, in Secs. 3.1 and 3.2. An exception in this dataset is inference for the never-discussants, which occurs because the observed completion rate for the non-discussants under control arm (Table   1) is zero. This is, generally, a mixture of completion rates of discussion-compliers and neverdiscussants assigned control, and therefore, here, both of these rates are zero. However, most of the other 95% intervals, including for the effect on discussion-compliers, are too wide for practical use or interpretation with this model.
In contrast, the model that uses age in both the compliance and the outcome components provides 95% posterior intervals that are quite usefully narrower than those of the model without age. In particular, among compliers, the effect of assignment on completion rates has a posterior mean of 62% and is most likely at least 34% (2.5% posterior quantile). These estimates are also substantially higher than those reported by the ITT analyses in Table 1 , and reflect in a principled way the uncertainty from the different sources of missing information.
The other results are generally not surprising, except perhaps the negative estimates for the effect of encouragement among always-discussants. Nevertheless, because the zero effect is well within the posterior interval in both models, this result is consistent with random fluctuation. Moreover, because in this application the proportion of always-takers is low, imposing a priori the exclusion restriction would not substantially change the results. In other applications where this assumption would be plausible and with larger proportions of always-takers, it would be beneficial to formulate this assumption explicitly in the model. Table 3 about here It is relevant to check the extent to which the increased precision of the second model-based procedure can be attributed to information in the data, including the ability of age to predict compliance principal strata, or information supplied by the prior distribution. In Table 3 
), and (iv) if the stratum is "complier", we calculate pr$
) and, with this probability, draw a Bernoulli outcome 4 $ 2 (
. The distributions for the other entries are derived analogously. None of these distributions appears particularly informative for the estimands summarized in Table 2 , suggesting that the increased precision in the model with age in Table 2 is not particularly influenced by the chosen prior distributions.
Moreover, the posterior distributions of the model parameters showed evidence that the probability of being a never-discussant decreased with age (mean, [2.5%, 97.5%] quantiles for Based on these results, the estimates obtained from the second model-based procedure are expected to be more appropriate for the compliance principal stratum-specific effects than either the estimated bounds or the first model estimates. Taking the effect of encouragement on the discussion-compliers to be the relevant estimand for the effect of AD discussions on AD completion, these results give support to, and considerably strengthen, the hypothesis that physician-discussion can substantially increase patient-completion of AD forms.
4¡ 3. Other models.
More than twenty other models of the form (3¡ 3)-(3¡ 7) were fit, were we varied the link functions § ë d
and § © d
, the functional forms for age, and the inflating factor º in (3¡ 6). In addition, in a preliminary effort in this work (Frangakis et al., 1998) , we had also tried logistic mixed effects analogues to the probit models reported here. Those models gave results mostly similar to the ones presented in Table 2 here (see, for example, Table 2 of Frangakis et al., 1998) , although with varying performance in the criteria of (i) degree in which the prior distributions influenced the results in the sense of the measures in Table 3 ; and (ii) convergence diagnostics.
For example, in contrast to the models in Sec. 3.3, the simulation stage for the logistic mixed effects model, after incorporation of Metropolis-Hastings adjustments to address lack of conjugacy, did not pass the convergence diagnostics of Gelman and Rubin (1992) (see also appendix)
within a satisfactory time. Among the models we tried, the two reported in the previous section were the most acceptable with respect to these two criteria. We did not consider models with residual dependence between the potential outcomes conditionally on stage (3¡ 4), or with assignment-arm differences in the term § ª © d
for physician-specific random parameters.
REMARKS
We described methodology for causal inference in studies with randomization in clusters but noncompliance at the individual level. The proposed method improves upon current procedures, which face limitations with respect to either validity or precision in estimation.
Our procedure is designed to be Bayesian for the input prior. In general, of course, a posterior interval does not automatically share the property of a confidence interval just as the latter does not automatically share the property of the former. It would be interesting to study frequency calibration of Bayesian procedures in this problem, for example, by asymptotics that allow information from covariates to grow with samples size, as mentioned in Sec. 3.2, or by mixing permutation distributions with the Bayesian model (e.g., Rubin, 1998) .
Our methods assume all-or-none observed compliance. For situations where observed compliance is continuous or multilevel, an approach that would discretize compliance to two (or few) levels can still be practically useful, as is often common practice with continuous variables (e.g., age simplified to young/old) where appropriate. Alternatively, direct modeling of the multiple compliance principal strata can be done by using appropriate assumptions on the parameters.
For an example, suppose that from a study's continuous compliance measure we create # Ë H % P R Q to have three ordered levels, labeled 2, 1, and 0, roughly representing, respectively, full dose, half dose, and, no dose of the new treatment. Then, there are generally 9 principal strata
. Suppose further that the behavioral or pharmacological context of that study makes the following three assumptions plausible. First, the exclusion restriction holds, i.e.,
. Second, encouragement to the new treatment increases receipt of dose of the new treatment both within and across subjects in the following sense:
Multilevel Monotonicity.
(a) (within subjects):
, and
Multilevel monotonicity allows for a total of 5 principal strata, three with treatment receipt unchangeable by encouragement (# =(0,0), (1,1), or (2,2)), and two with treatment receipt increasing by 1 dose with encouragement (# = (0,1) or (1,2)). A third assumption, then, can be that for the last two groups, the effect of encouragement on outcomes is the same, e.g., in the scale of relative risk:
Then it can be proven that, under the above conditions, the causal effect ¿ , as well as all other unknown components of the distributions, are consistently estimable. As in Sec. 3.2, some of the assumptions can be relaxed with the help of covariates or by substitution with alternative assumptions. It is then relevant to explore the plausibility of such assumptions in the study context, and compare results to alternative methods. Details and applications of this approach to multilevel compliance will be discussed in the future.
More generally, it is precisely the emphasis of this approach on the existence of principal strata of compliance that allows the researcher to input into analyses explicit scientific assumptions.
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A 1. Any missing compliance principal stratum is drawn at this step from pr
. This distribution is obtained from the joint distribution pr
For example, a subject with
can be either a complier or a never-taker, and the
where we define
Therefore, the conditional probability of the subject being a complier at this step is
The drawing of b D
for subjects with
is done in a similar way.
2. The missing potential outcome,
, of each person is drawn from the Bernoulli distribution with probability is based on the remaining 37500 iterations, combining the three chains. (Cochran, 1963, p. 30) ; (data modified from Frangakis and Baker, 2001 , to report results of clustering for finite study population). Posterior predictive distribution of probabilities of being a discussion-complier (mean is height of lower solid curve), a never-discussant (mean is height between solid curves), and an alwaysdiscussant (mean is height between upper solid curve and 1.0). The two dotted lines around the lower (upper) solid curve are å ¥ posterior standard deviation of the probability of complier (always-discussant) (see also Sec. 4.2).
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